"Prostatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PROSTATE.
Descriptor ID |
D011471
|
MeSH Number(s) |
C04.588.945.440.770 C12.294.260.750 C12.294.565.625 C12.758.409.750
|
Concept/Terms |
Prostatic Neoplasms- Prostatic Neoplasms
- Prostate Neoplasms
- Neoplasms, Prostate
- Neoplasm, Prostate
- Prostate Neoplasm
- Neoplasms, Prostatic
- Neoplasm, Prostatic
- Prostatic Neoplasm
Prostate Cancer- Prostate Cancer
- Cancer, Prostate
- Cancers, Prostate
- Prostate Cancers
- Cancer of the Prostate
- Prostatic Cancer
- Cancer, Prostatic
- Cancers, Prostatic
- Prostatic Cancers
- Cancer of Prostate
|
Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms".
This graph shows the total number of publications written about "Prostatic Neoplasms" by people in this website by year, and whether "Prostatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 3 | 0 | 3 |
1996 | 2 | 0 | 2 |
1997 | 7 | 0 | 7 |
1998 | 3 | 0 | 3 |
1999 | 1 | 1 | 2 |
2000 | 2 | 0 | 2 |
2001 | 3 | 0 | 3 |
2002 | 5 | 0 | 5 |
2003 | 5 | 1 | 6 |
2004 | 4 | 3 | 7 |
2005 | 9 | 1 | 10 |
2006 | 8 | 1 | 9 |
2007 | 14 | 2 | 16 |
2008 | 5 | 1 | 6 |
2009 | 14 | 0 | 14 |
2010 | 15 | 2 | 17 |
2011 | 8 | 0 | 8 |
2012 | 4 | 0 | 4 |
2013 | 12 | 1 | 13 |
2014 | 9 | 0 | 9 |
2015 | 12 | 0 | 12 |
2016 | 8 | 1 | 9 |
2017 | 6 | 1 | 7 |
2018 | 2 | 0 | 2 |
2019 | 6 | 0 | 6 |
2020 | 9 | 0 | 9 |
2022 | 7 | 0 | 7 |
2023 | 4 | 1 | 5 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prostatic Neoplasms" by people in Profiles.
-
Bridging the Gap: A Community Advisory Board Promoting Community Engagement in Cancer Research for Ethnically Diverse Populations. Am J Mens Health. 2024 Sep-Oct; 18(5):15579883241280826.
-
SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A. JCI Insight. 2023 Oct 23; 8(20).
-
Re: Clinical utility of multiple secondary combined tests in prostate cancer screening. Can J Urol. 2023 06; 30(3):11545.
-
Potential role for protein kinase D inhibitors in prostate cancer. J Mol Med (Berl). 2023 Apr; 101(4):341-349.
-
EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy. Oncogene. 2023 03; 42(12):861-868.
-
Decursin inhibits EGFR-ERK1/2 signaling axis in advanced human prostate carcinoma cells. Prostate. 2023 May; 83(6):534-546.
-
Re: "The Effect of prior prostate cancer treatment on perioperative and pathological outcomes after cystectomy". Can J Urol. 2022 10; 29(5):11291.
-
Presenting signs and symptoms of artificial urinary sphincter cuff erosion. Int Braz J Urol. 2022 Jul-Aug; 48(4):679-685.
-
Strengthening Capacity for Prostate Cancer Early Diagnosis in West Africa Amidst the COVID-19 Pandemic: A Realist Approach to Rethinking and Operationalizing the World Health Organization 2017 Guide to Cancer Early Diagnosis. Ann Glob Health. 2022; 88(1):29.
-
PGC1 alpha coactivates ERG fusion to drive antioxidant target genes under metabolic stress. Commun Biol. 2022 05 04; 5(1):416.